Cargando…
Recent advances in the management of immune-mediated thrombotic thrombocytopenic purpura
Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a potentially life-threatening thrombotic microangiopathy caused by autoantibody-mediated severe ADAMTS13 deficiency. TTP should be suspected in patients with microangiopathic hemolytic anemia and thrombocytopenia without a definite cause...
Autores principales: | Bae, Sung Hwa, Kim, Sung-Hyun, Bang, Soo-Mee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057674/ https://www.ncbi.nlm.nih.gov/pubmed/35483924 http://dx.doi.org/10.5045/br.2022.2022005 |
Ejemplares similares
-
Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018) -
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023) -
Hereditary Thrombotic Thrombocytopenic Purpura
por: Nusrat, Sanober, et al.
Publicado: (2023) -
Management of thrombotic thrombocytopenic purpura: current perspectives
por: Blombery, Piers, et al.
Publicado: (2014) -
Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
por: Sukumar, Senthil, et al.
Publicado: (2021)